Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 22, 2013 - Issue 6: Protein Kinase Inhibitors
Submit an article Journal homepage
2,039
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Protein kinase inhibitors: breakthrough medicines and the next generation

Tomi K SawyerAileron Therapeutics, Cambridge, MA 02139, [email protected]
,
Joe C WuGlaxoSmithKline PLC, Cambridge, MA 02139, USA
,
Jonathon R SawyerProvidence College, Providence, RI 02908, USA
&
Jessie M EnglishBelfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute, Boston, MA 02115, USA
Pages 675-678 | Published online: 25 May 2013

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jaime Berumen, Ana María Espinosa & Ingrid Medina. (2014) Targeting CDKN3 in cervical cancer. Expert Opinion on Therapeutic Targets 18:10, pages 1149-1162.
Read now
Håkon Reikvam, Ina Nepstad & Jerome Tamburini. (2013) Predicting effects of kinase inhibitor in therapy for myeloid malignancies – the challenges in capturing disease heterogeneity. Expert Opinion on Investigational Drugs 22:11, pages 1365-1370.
Read now

Articles from other publishers (5)

Yu Chen. Progress in research on protein tyrosine kinase inhibitors. Progress in research on protein tyrosine kinase inhibitors.
Kai-Cheng Hsu, Tzu-Ying Sung, Chih-Ta Lin, Yi-Yuan Chiu, John T.-A. Hsu, Hui-Chen Hung, Chung-Ming Sun, Indrajeet Barve, Wen-Liang Chen, Wen-Chien Huang, Chin-Ting Huang, Chun-Hwa Chen & Jinn-Moon Yang. (2015) Anchor-based classification and type-C inhibitors for tyrosine kinases. Scientific Reports 5:1.
Crossref
ANDRES SILVA, JENNIE WANG, SARAH LOMAHAN, TUAN-ANH TRAN, LAURA GRENLIN, AKIKO SUGANAMI, YUTAKA TAMURA & NAOHIKO IKEGAKI. (2014) Aurora kinase A is a possible target of OSU-03012 to destabilize MYC family proteins. Oncology Reports 32:3, pages 901-905.
Crossref
Saurabh Prabhu, Frederick Harris, Robert Lea & Timothy J. Snape. (2014) Small-molecule clinical trial candidates for the treatment of glioma. Drug Discovery Today 19:9, pages 1298-1308.
Crossref
Sarah K. Maenhout, Stephanie Du Four, Jurgen Corthals, Bart Neyns, Kris Thielemans & Joeri L. Aerts. (2014) AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells. Oncotarget 5:16, pages 6801-6815.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.